NCT00103350View on ClinicalTrials.gov

Safety of TG100-115 for Heart Attack Treated With Angioplasty

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

December 31, 2006

Study Completion Date

January 31, 2008

Conditions

Myocardial Infarction

Interventions

DRUG

TG100-115

Trial Locations (1)

55905

David Holmes, MD, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors

lead

TargeGen

INDUSTRY